1.
Gedeborg R, Sandin F, Thellenberg-Karlsson C, Styrke J, Franck Lissbrant I, Garmo H, et al. Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in Sweden. SJU [Internet]. 2023 Nov. 9 [cited 2024 Aug. 4];58:93-100. Available from: https://medicaljournalssweden.se/SJU/article/view/9572